Characteristics of patients Values are given as total numbers and percentages or mean ± S.D.
Heparin | Bivalirudin | p | |
|---|---|---|---|
| (n = 15) | (n = 15) | ||
| Male | 9 (60.0%) | 13 (86.7%) | 0.22 |
| Female | 6 (40.0%) | 2 (13.3%) | |
| Age (year) | 66.8 ± 9.6 | 66.1 ± 7.9 | 0.82 |
| Body mass index (kg/m2) | 27.0 ± 4.9 | 28.1 ± 3.5 | 0.48 |
| Hypertension | 15 (100%) | 15 (100%) | 1.0 |
| Hyperlipidemia | 10 (73.3%) | 11 (73.3%) | 1.0 |
| Diabetes mellitus | 3 (20%) | 7 (46.7%) | 0.25 |
| Current smoker | 3 (20%) | 0 (0%) | 0.22 |
| Family history | 1 (6.7%) | 2 (13.3%) | 1.0 |
| Low-density lipoprotein cholesterol (mg/dl) | 91.5 ± 20.5 | 103.0 ± 38.9 | 0.32 |
| High-density lipoprotein cholesterol (mg/dl) | 48.1 ± 10.5 | 48.3 ± 8.5 | 0.97 |
| Triglycerides (mg/dl) | 103.7 ± 32.8 | 93.3 ± 30.5 | 0.38 |
| Activated clotting time (s) | 312.2 ± 41.7 | 301.5 ± 39.4 | 0.56 |
| Systolic blood pressure (mm Hg) | 131.3 ± 15.2 | 131.2 ± 15.6 | 0.98 |
| Diastolic blood pressure (mm Hg) | 80.3 ± 6.7 | 78.3 ± 8.4 | 0.48 |
| Heart rate (beats/min) | 68.1 ± 8.0 | 65.2 ± 12.0 | 0.45 |
| Acetylsalicylic acid | 15 (100%) | 15 (100%) | 1.0 |
| Beta-blockers | 14 (93.3%) | 15 (100%) | 1.0 |
| Statins | 12 (80%) | 13 (86.7%) | 1.0 |
| Angiotensin-converting enzyme inhibitor | 13 (86.7%) | 12 (80%) | 1.0 |
| AT1 receptor blocker | 2 (13.3%) | 1 (6.7%) | 1.0 |